Tackling the Challenge of Serialisation and Traceability
Contributor:
Pharma IQ
Posted: 09/15/2010 12:00:00 AM EDT | 0
Posted: 09/15/2010 12:00:00 AM EDT | 0
|
As counterfeit drug sales become increasingly costly to both pharmaceutical manufacturers and patients, companies are attempting to address the challenges of serialisation and traceability to reduce the burden on health services across the world.
-
Using Software to Boost Clinical Trial Design -
FDA Guidelines -
Patients Must Always be the Priority -
Making Drug Distribution a Global Proposition -
Heavy Investment in CER will not Transform the US Healthcare System -
Using Genotoxicity Tests to Push Drug Development Forward -
In Demand: Prefilled Syringes -
Effective Information Management to Aid Regulatory Submissions: What Do You Do to Make it Work in Practice? -
Middle East North Africa Pharmaceutical Market - In Transition -
Securing the Supply Chain to Combat Counterfeit Medicines
* = required.
Not a member yet? Sign up
You Should Check Out:
Events of Interest
-
Serialization 2/0 - Getting Prepared for the Future of Pharma Supply Chain Security
December 13, 2011
Register Now -
Guarantee GDP- Compliant Cool Chain Logistics for Pharmaceuticals to CEE & CIS Countries
January 16, 2013
Register Now -
Pharma 2020: Which path will you take?
November 22, 2012
Register Now -
Adverse Event Reporting Online Training Course 2011
August 3, 2011
Register Now




Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!